Mash Premiere

Mash Premiere stands as a prominent pharmaceutical entity within the Egyptian market, dedicated to elevating life quality across the MENA Region and Africa through robust local manufacturing and pioneering pharmaceutical solutions. Established in 1986, the company has cultivated a diverse portfolio, featuring over 110 products that span critical therapeutic areas such as anti-infectives, dietary supplements, antifungals, and antivirals, complemented by an extensive product pipeline. Operating with a revenue of $124.5M and employing between 500 - 1,000 individuals, Mash Premiere demonstrates significant scale and operational capacity. Its strategic focus on enhancing patient care and upholding stringent quality standards positions it as a key player in the healthcare sector. The company actively pursues ambitious growth objectives, aiming to rank among the top 10 pharmaceutical companies by 2025, underscoring its commitment to market leadership and innovation. Mash Premiere fosters a supportive workplace environment and demonstrates a strong commitment to corporate social responsibility through active engagement in community benefit initiatives. Meet Mash Premiere's team to learn more about the dedicated professionals driving these efforts and contributing to the company's mission of improving health outcomes.